Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation

Journal of Cardiology

Volumn 63, Issue 2, 2014, Pages 123-127

  Senoo, Keitaro ^a   Suzuki, Shinya ^a   Sagara, Koichi ^a   Otsuka, Takayuki ^a   Matsuno, Shunsuke ^a   Uejima, Tokuhisa ^a   Oikawa, Yuji ^a   Yajima, Junji ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Lip, Gregory Y H ^b   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Coronary artery disease; Incidence; Nonvalvular atrial fibrillation; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHADS2 SCORE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DATA BASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONVALVULAR ATRIAL FIBRILLATION; PREDICTOR VARIABLE; PREVALENCE; PROGNOSIS; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

CORONARY ARTERY DISEASE; INCIDENCE; NONVALVULAR ATRIAL FIBRILLATION; PROGNOSIS;

AGE FACTORS; AGED; ANGINA, STABLE; ANGINA, UNSTABLE; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HOSPITALS; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREVALENCE; SEX FACTORS; TIME FACTORS;

EID: 84893729209     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.08.007     Document Type: Article

References (32)

1. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
2. Flegel K.M., Shipley M.J., Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987, 1:526-529.
3. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 1983, 106:389-396.
4. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995, 98:476-484.
5. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96:2455-2461.
6. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 1998, 32:695-703.
7. Lip G.Y., Beevers D.G. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ 1995, 311:1361-1363.
8. Schoonderwoerd B.A., Van Gelder I., Crijns H.J. Left ventricular ischemia due to coronary stenosis as an unexpected treatable cause of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1999, 10:224-228.
9. Wattigney W.A., Mensah G.A., Croft J.B. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol 2002, 155:819-826.
10. Suzuki S., Yamashita T., Otsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008, 72:914-920.
11. Suzuki S., Yamashita T., Otsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo. J Cardiol 2011, 58:116-123.
12. Suzuki S., Yamashita T., Ohtsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Yamazaki T., Aizawa T. Body size and atrial fibrillation in Japanese outpatients. Circ J 2010, 74:66-70.
13. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
14. Van Gelder I.C., Groenveld H.F., Crijns H.J., Tuininga Y.S., Tijssen J.G.P., Alings A.M., Hillege H.L., Bergsma-Kadijk J.A., Cornel J.H., Kamp O., Tukkie R., Bosker H.A., Van Veldhuisen D.J., Van den Berg M.P. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010, 362:1363-1373. RACE II Investigators.
15. Kralev S., Schneider K., Lang S., Süselbeck T., Borggrefe M. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS ONE 2011, 6:e24964.
16. Hohnloser S.H., Crijns H.J., van Eickels M., Gaudin C., Page R.L., Torp-Pedersen C., Connolly S.J. N Engl J Med 2009, 360:668-678.
17. Wyse D.G., Waldo A.L., DiMaroco J.P. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002, 347:1834-1840. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators.
18. Ogawa S., Yamashita T., Yamazaki T., Aizawa Y., Atarashi H., Inoue H., Ohe T., Ohtsu H., Okumura K., Katoh T., Kamakura S., Kumagai K., Kurachi Y., Kodama I., Koretsune Y., et al. Circ J 2009, 73:242-248.
19. Akao M., Chun Y.H., Wada H., Esato M., Hashimoto T., Abe M., Hasegawa K., Tsuji H., Furuke K., Fushimi A.F. J Cardiol 2013, 61:260-266.
20. Miyasaka Y., Barnes M., Gersh B.J., Cha S.S., Bailey K.R., Seward J.B., Iwasaka T., Tsang T.S. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med 2007, 120:357-363.
21. Naccarelli G.V., Panaccio M.P., Cummins G., Tu N. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients. Am J Cardiol 2012, 109:1526-1533.
22. Goto S., Bhatt D., Rother J., Alberts M., Hill M.D., Ikeda Y., Uchiyama S., D'Agostino R., Ohman E.M., Liau C.S., Hirsch A.T., Mas J.L., Wilson P.W., Corbalán R., Aichner F., et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008, 156:855-863.
23. Go A.S., Hylek E.M., Chang Y., Phillips K.A., Henault L.E., Capra A.M., Jensvold N.G., Selby J.V., Singer D.E. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practiceα JAMA 2003, 290:2685-2692.
24. Suttorp M.J., Kingma J.H., Koomen E.M., van't Hof A., Tijssen J.G., Lie K.I. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993, 71:710-713.
25. Flaker G.C., Belew K., Beckman K., Vidaillet H., Kron J., Safford R., Mickel M., Barrell P. Am Heart J 2005, 149:657-663.
26. Corley S.D., Epstein A.E., DiMarco J.P., Domanski M.J., Geller N., Greene H.L., Josephson R.A., Kellen J.C., Klein R.C., Krahn A.D., Mickel M., Mitchell L.B., Nelson J.D., Rosenberg Y., Schron E., et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109:1509-1513.
27. Curtis A.B., Gersh B.J., Corley S.D., DiMarco J.P., Domanski M.J., Geller N., Greene H.L., Kellen J.C., Mickel M., Nelson J.D., Rosenberg Y., Schron E., Shemanski L., Waldo A.L., Wyse D.G., et al. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005, 149:645-649.
28. Maehama T., Okura H., Imai K., Yamada R., Obase K., Saito K., Hayashida A., Neishi Y., Kawamoto T., Yoshida K. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation. Am J Cardiol 2010, 106:535-538.
29. Momiyama Y., Kawaguchi A., Kajiwara I., Ohmori R., Okada K., Saito I., Konishi M., Nakamura M., Sato S., Kokubo Y., Mannami T., Adachi H., Kario K., Iso H., Ohsuzu F., et al. Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 2009, 207:272-276.
30. Singer D.E., Albers G.W., Dalen J.E., Go A.S., Halperin J.L., Manning W.J. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(3 Suppl.):429S-456S.
31. Inoue H. Thromboembolism in patients with nonvalvular atrial fibrillation: comparison between Asian and Western countries. J Cardiol 2013, 61:1-7.
32. European Association for Cardio-Thoracic Surgery, Camm A.J., Kirchhof P., Lip G.Y., Schotten U., Savelieva I., Ernst S., Van Gelder I.C., Al-Attar N., Hindricks G., Prendergast B., Heidbuchel H., Alfieri O., Angelini A., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429. European Heart Rhythm Association.